Developing Pharmaceutical Legislation in the Federated States of Micronesia
Date
2021-11-12
Authors
Puas, Gonzaga
Samo, Marcus
Journal Title
Journal ISSN
Volume Title
Publisher
Canberra, ACT: Dept. of Pacific Affairs, Coral Bell School of Asia Pacific Affairs, The Australian National University
Abstract
In the Federated States of Micronesia (FSM), pharmacies are largely unregulated, giving rise to a lack of quality control over medicines and potentially exposing the public to harmful consequences. A joint state and national response was to adopt the FSM Medicine Policy in 2012 which served as guidance for the pharmaceutical industry (DHSA 2012). A 2017 review of the sector found that a legislative and regulatory regime is urgently required to assure quality control and thus increase the public’s confidence in the medicines available (DHSA 2017). Assistance from the World Health Organization (WHO) and Australia was provided to collaborate with the Department of Health and Social Affairs for the purposes of creating the legislative framework. This In Brief provides an overview of the existing pharmaceutical legal regime and the legislative framework that has been proposed to replace it.
Description
Keywords
Federated States of Micronesia, FSM, Pharmaceutical companies, Big Pharma, Legislations, Law, governance, Regulations, Coronavirus, Covid-19
Citation
Collections
Source
Type
Journal article
Book Title
Entity type
Access Statement
Open Access